These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1298391)

  • 1. Assessment of chromatographic peak purity of drugs by multivariate analysis of diode-array and mass spectrometric data.
    Lincoln D; Fell AF; Anderson NH; England D
    J Pharm Biomed Anal; 1992; 10(10-12):837-44. PubMed ID: 1298391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intelligent peak deconvolution through in-depth study of the data matrix from liquid chromatography coupled with a photo-diode array detector applied to pharmaceutical analysis.
    Arase S; Horie K; Kato T; Noda A; Mito Y; Takahashi M; Yanagisawa T
    J Chromatogr A; 2016 Oct; 1469():35-47. PubMed ID: 27712885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF.
    Can NÖ
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30029473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purity assessment of crystalline zearalenone.
    Krska R; Welzig E; Josephs RD; Kandler W; Pettersson H; MacDonald S; Charlton A; Brereton P; Hametner C; Berner D; Zöllner P
    J AOAC Int; 2003; 86(4):722-8. PubMed ID: 14509431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current developments in LC-MS for pharmaceutical analysis.
    Lim CK; Lord G
    Biol Pharm Bull; 2002 May; 25(5):547-57. PubMed ID: 12033491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impurity profile tracking for active pharmaceutical ingredients: case reports.
    Zhou L; Mao B; Reamer R; Novak T; Ge Z
    J Pharm Biomed Anal; 2007 Jun; 44(2):421-9. PubMed ID: 17142001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated peak tracking for comprehensive impurity profiling in orthogonal liquid chromatographic separation using mass spectrometric detection.
    Xue G; Bendick AD; Chen R; Sekulic SS
    J Chromatogr A; 2004 Oct; 1050(2):159-71. PubMed ID: 15508308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an improved general unknown screening procedure using liquid chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography--diode array detection.
    Saint-Marcoux F; Lachâtre G; Marquet P
    J Am Soc Mass Spectrom; 2003 Jan; 14(1):14-22. PubMed ID: 12504330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peak purity determination with principal component analysis of high-performance liquid chromatography-diode array detection data.
    Wiberg K; Andersson M; Hagman A; Jacobsson SP
    J Chromatogr A; 2004 Mar; 1029(1-2):13-20. PubMed ID: 15032344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced monitoring of biopharmaceutical product purity using liquid chromatography-mass spectrometry.
    Laursen K; Justesen U; Rasmussen MA
    J Chromatogr A; 2011 Jul; 1218(28):4340-8. PubMed ID: 21621780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple heart-cutting two dimensional liquid chromatography mass spectrometry: Towards real time determination of related impurities of bio-pharmaceuticals in salt based separation methods.
    Petersson P; Haselmann K; Buckenmaier S
    J Chromatogr A; 2016 Oct; 1468():95-101. PubMed ID: 27667648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Impurity-Profiling Workflow with the Combination of Flash-Chromatography, UHPLC-MS, and Multivariate Data Analysis for Highly Pure Drugs: A Study on the Synthetic Cannabinoid MDMB-CHMICA.
    Münster-Müller S; Zimmermann R; Pütz M
    Anal Chem; 2018 Sep; 90(17):10559-10567. PubMed ID: 30079731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supercritical fluid chromatography-photodiode array detection-electrospray ionization mass spectrometry as a framework for impurity fate mapping in the development and manufacture of drug substances.
    Pirrone GF; Mathew RM; Makarov AA; Bernardoni F; Klapars A; Hartman R; Limanto J; Regalado EL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():42-49. PubMed ID: 29477066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of liquid chromatography with mass spectrometry combined with photodiode array detection and tandem mass spectrometry for monitoring pesticides in surface waters.
    Jeannot R; Sabik H; Sauvard E; Genin E
    J Chromatogr A; 2000 May; 879(1):51-71. PubMed ID: 10870695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrafast liquid chromatography/ultraviolet and liquid chromatography/tandem mass spectrometric analysis.
    Cheng Y; Lu Z; Neue U
    Rapid Commun Mass Spectrom; 2001; 15(2):141-51. PubMed ID: 11180543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.